Brief: Immunovia Completes IMMray PanCan-d Commercial Test Model Study With High Accuracy

Immunovia AB (publ)

19/12/2019 11:43

Dec 19 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * SUCCESSFUL COMPLETION OF IMMRAY TM  PANCAN-D COMMERCIAL
TEST
MODEL STUDY WITH HIGH ACCURACY
    * IMMRAY(TM) PANCAN-D COMMERCIAL TEST FOR EARLY STAGE
DETECTION OF
PANCREATIC CANCER REMAINS ON TRACK FOR SALES START Q3 2020

Source text for Eikon:  ID:nWkrbJSTt9 
Further company coverage:  IMMNOV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))